Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry
Author:
Funder
Novo Nordisk
AstraZeneca
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference29 articles.
1. Standards of medical care in diabetes;Association;Diabetes Care,2017
2. Microvascular and macrovascular complications of diabetes;Fowler;Clin Diabetes,2011
3. Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study;Nicolucci;Diabetes Res Clin Pract,2022
4. Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: insights from the DISCOVER prospective cohort study;Arnold;Endocrinol Diabetes Metab,2022
5. American diabetes A. Economic costs of diabetes in the US in 2002;Hogan;Diabetes Care,2003
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Second-year results from CINEMA: A novel, patient-centered, team-based intervention for patients with Type 2 diabetes or prediabetes at high cardiovascular risk;American Journal of Preventive Cardiology;2024-03
2. Prescribing Patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Patients with T2DM and ASCVD in South Korea;2024-01-30
3. Differential effects of OATP2B1 on statin accumulation and toxicity in a beta cell model;Toxicology Mechanisms and Methods;2023-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3